Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 38 (25), 2329-2337
- https://doi.org/10.1016/0024-3205(86)90640-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Phencyclidine receptors in rat brain cortexBiochemical Pharmacology, 1984
- An early Phase II clinical trial of BW234U in the treatment of acute schizophrenia in newly admitted patientsPsychopharmacology, 1984
- The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activityEuropean Journal of Pharmacology, 1984
- Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.Proceedings of the National Academy of Sciences, 1984
- BW234U,(cis-9-[3–(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agentJournal of Pharmacy and Pharmacology, 1982
- Novel opiate binding sites selective for benzomorphan drugs.Proceedings of the National Academy of Sciences, 1981
- DEMONSTRATION OF [CYCLAZOCINE-H-3 BINDING TO MULTIPLE OPIATE RECEPTOR-SITES1981
- High-Dose Propranolol in SchizophreniaThe British Journal of Psychiatry, 1979
- Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.Journal of Biological Chemistry, 1979